CN108519267A - The method and products thereof of detection microorganism is composed by internal standard material - Google Patents

The method and products thereof of detection microorganism is composed by internal standard material Download PDF

Info

Publication number
CN108519267A
CN108519267A CN201810345986.4A CN201810345986A CN108519267A CN 108519267 A CN108519267 A CN 108519267A CN 201810345986 A CN201810345986 A CN 201810345986A CN 108519267 A CN108519267 A CN 108519267A
Authority
CN
China
Prior art keywords
internal standard
molecular weight
microorganism
detection
standard object
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810345986.4A
Other languages
Chinese (zh)
Other versions
CN108519267B (en
Inventor
战晓微
马庆伟
宋召
谭甜霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Yixin Bochuang Biological Technology Co Ltd
Original Assignee
Beijing Yixin Bochuang Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Yixin Bochuang Biological Technology Co Ltd filed Critical Beijing Yixin Bochuang Biological Technology Co Ltd
Priority to CN201810345986.4A priority Critical patent/CN108519267B/en
Publication of CN108519267A publication Critical patent/CN108519267A/en
Application granted granted Critical
Publication of CN108519267B publication Critical patent/CN108519267B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/64Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode using wave or particle radiation to ionise a gas, e.g. in an ionisation chamber
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electrochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The present invention provide it is a kind of by internal standard object come the method for Mass Spectrometer Method microorganism, which has known molecular weight and mass-to-charge ratio, and the peak value spectrogram of microorganism characteristic protein is not interfered during microorganism detection.The present invention also provides internal standard object combination, reagent composition and its coherent detection products.The method of internal standard material correction single microbial sample detection is utilized in the present invention, it is applicable to include fungi, in all kinds of microbiological specimens for MALDI TOF MS detections such as bacterium, the accuracy rate of microbial identification is improved, while compensating for and only having external perimysium reference object to do the deficiency corrected currently on the market.

Description

The method and products thereof of detection microorganism is composed by internal standard material
Technical field
The invention belongs to biotechnology, it is related in the detection of flight time mass spectrum system detectio microbiological specimens Calibration is just.
Background technology
Matrix-Assisted Laser Desorption Ionization Time of Flight (Matrix-assisted laser desorption Lionization time of flight mass spectrometry, MALDI-TOF-MS) technology is rapidly to send out in recent years One of the proteomics of exhibition, genomics technologies have the characteristics that high sensitivity, accuracy be high and high resolution, are life Analysis means of testing of the scientific research with the clinical offers such as major disease early warning and auxiliary diagnosis quickly, high-throughput be also simultaneously A kind of method of good identification pathogenic microorganism.
The principle of MALDI-TOF-MS is to use laser irradiation sample and substrate formed cocrystallization film, and matrix is from laser Energy transmission is absorbed to biomolecule, and obtains proton by proton translocation to biomolecule or from biomolecule in ionization process, And the process for making biomolecule ionize.The principle of TOF is that ion accelerates to fly over dirft tube under electric field action, is examined according to reaching The mass-to-charge ratio (M/Z) surveyed the flight time difference of device and be detected i.e. measurement ion is directly proportional to the flight time of ion, detection Ion.Although the accuracy of MALDI-TOF-MS is up to 0.1%~0.01%, the SDS electrophoresis significantly larger than routinely applied at present With high productivity computing technology.MALDI-TOF MS technologies have the characteristics that quick, accurate, stable, high-throughput, low cost; MALDI-TOF MS technologies are the quick analytical technology of routine of Clinical microorganism and one of the analytical technology of drug-resistant microorganism; MALDI-TOF MS technologies provide effective identification technology for the structure of pathogen resources bank and support.But due to systematic error Etc. factors influence the accurate quantification of experimental result and introduce the internal standard of known concentration and ratio therefore in Mass Spectrometer Method sample, from And improve accuracy and the precision of single microbial sample identification.
The method of curve matching at home and abroad has more universal application, Jiangyue Wu etc. at present (Anal.Chem.1997,69,3767-3771) cyclosporin is quantified using the matched curve method of MALDI-TOF-MS Test;Mazarin etc. (Anal.Chem.2006,78,2758-2764) combines pulsed gradient spinning NMR and MALDI- When TOF-MS quantitative determines polymer, equally uses matched curve and carry out Data correction;2009, Lv Shuan et al. utilized fitting Curve successfully develops a kind of MALDI-TOF-MS quantitative approach of Phosphorylated Peptide.
The technology is that the cracking of acidic matrix auxiliary cell, laser excitation cell lysate are added in complete microorganism (little albumen or polypeptide) forms peptide mapping fingerprinting, is compared with the general character reference spectrum library of the genus and species level built, To realize the identification of microorganism.And the testing result of various feature peptides or peptide fingerprint has specific mass-to-charge ratio by a series of (M/Z) peak curve is identified.It is protein fingerprint spectrum in the accuracy using MALDI-TOF MS mass spectrograph collecting samples Microorganism identifies the key factor of system, if since the impurity of cell lysate or systematic error (continue in detection process Supplement) influence, the peak curve of testing result can be caused a degree of error (such as the peak of 1-10 Da molecular weight occur Value offset), therefore generally require and be corrected by reference substance, so that measuring peak curve and true peak curves.
Yuan Xianglin etc. (《Analytical chemistry research report》, the 1st phase of volume 29 in 2001) and it reports in MATRIX-ASSISTED LASER solution Ionization time of flight mass spectrometry is inhaled in the quantitative analysis of Ginsenoside Rg3, selecting rutin as internal standard compound, in reproducibility and line Property aspect be better than gossypose.The raising of resolution ratio and testing concentration is represented with relative peak area, can make it is averagely opposite accidentally Difference is substantially reduced, and improves quantitative result.However, this method is not intended in Mass Spectrometer Method microorganism, examined with MALDI-TOF MS It is reflective-mode used by the quantitative analysis of Ginsenoside Rg3, and to be measured unlike the linear model that micrometer biology uses The detection range of sample is less than 1000Da, while its detection interval is only limitted to 400-900 (M/Z), cannot be satisfied the inspection of microorganism Section is surveyed, therefore is restricted.
Chinese patent application 2014100902157, denomination of invention " the polypeptide reference substance for early diabetes diagnosis " are public A kind of internal standard polypeptide for Mass Spectrometer Method early diabetes is opened, which derives from human serum albumins, has 19 ammonia Base acid sequence.It needs by period longer incubation time, while the internal standard peptide fragment judges to participate in result, by calculating mesh The ratio of peptide fragment and internal standard peptide fragment is marked to judge the risk possibility of having diabetes rather than the testing result of judgement sample itself Whether detect accurate.However, this method is equally not intended in MALDI-TOF MS detection microorganisms, detection range is respectively less than 1000Da differs more with microorganism detection range 2000Da-20000Da, cannot be satisfied the detection interval of microorganism, therefore by Limitation is arrived.
As the immediate prior art, " microbial identification is used for Chinese patent application 201510246677.8, denomination of invention Mass spectrograph molecular weight calibration standard items and the preparation method and application thereof " disclose one group using mass-to-charge ratio m/z be respectively 2094, 2466,3149,4364 etc. 18 Escherichia coli characteristic proteins for correction feature spectrogram, stablize correction effect as reference substance Fruit.However, although the reference substance involved in the invention can effectively detect microorganism, it must be carried out before Mass Spectrometer Method Parallel testing, to carry out molecular weight calibration to mass spectrograph and can not directly judge the accuracy of single sample testing result, still So belong to external perimysium reference object, step is increased in detection process, is unfavorable for the high-throughput, quick, just of a large amount of micro-biological samples Prompt detection.In conclusion to single when the mass spectrography detection sample standard deviation reported at present cannot meet identification micro-biological samples The correction of pattern detection, wherein MALDI-TOF MS methods, which only use in for quantitative determination, adds interior calibration method, and for MALDI-TOF MS methods identification microorganism there is no report.
At present in the market use MALDI-TOF-MS methods detection microorganism during, detection range is mainly 2000-20000Da (Calderaro etc.), although having been reported that (Pignone etc., Shah etc., Kumar etc., Edwards-Jones Deng) mass spectra peak of 400-3000Da be used to differentiate the research of parting etc., but the characteristic peak in the mass range not by with In the identification of commercially available MALDI-TOF-MS instruments.And in 2000-20000Da detection ranges, the principal character peak of microorganism is small In 12000Da (Winkler etc.), therefore in the research that existing laser mass spectrometry detects microorganism, external perimysium reference is still used Object, even a variety of external perimysium reference objects are corrected, to increase detection time and testing cost.Therefore, one kind is needed at present Pass through the new method of flight time mass spectrum system detectio microorganism characteristic protein.
Invention content
The principle of the invention is:Mass-to-charge ratio section (the 3000- of microorganism is detected according to existing MALDI-TOF-MS 13000m/z), it is put forward for the first time using less than 3000m/z or the single internal standard object more than 12000m/z, the internal standard object With known molecular weight and mass-to-charge ratio, the peak value of microorganism characteristic protein is not interfered to compose during microorganism detection Figure.Therefore, it is added to the internal standard object in each microbiological specimens to be checked, it is made to be produced simultaneously with each microbiological specimens Raw specific mass spectrogram, and by the known molecular amount of the reference substance and its corresponding characteristic peak, to correct each microorganism sample The mass spectrogram of product (is tested microorganism characteristic protein for example, according to the testing molecule amount of reference substance and the difference of actual molecular weight Molecule measuring magnitude be corrected, such as actual measured value is corrected according to the difference), to improve single microbial The accuracy of sample identification and precision.Since the internal standard material for correction that the present invention selects is selected in 1000- 3000Da or 13000-20000Da can not only reach detection result, also on the basis of not influencing microbial identification, add The internal standard material added can correct the entire spectrogram of single sample, may be caused in the detection with making up MALDI-TOF MS The deficiency of deviation.
Therefore, first purpose of the invention is to provide one kind by internal standard object come flight time mass spectrum detection microorganism Method, this method includes:
(1) pre-treatment is carried out to microbiological specimens;
(2) 1000Da is added in the microbiological specimens of preceding processing<Average molecular weight<3000Da or 12000Da<Average mark Son amount<The internal standard object of 20000Da;
(3) Mass Spectrometer Method will be carried out containing the microbiological specimens of internal standard object so that microbiological specimens and internal standard Object generates specific mass spectrogram simultaneously, and by the known molecular amount of the reference substance and its corresponding characteristic peak, each to correct The mass spectrogram of microbiological specimens, to obtain accurate testing result;
Wherein, the internal standard object can be in above-mentioned average molecular weight known polypeptide or/and protein standard substance or A combination thereof.
In one embodiment, the internal standard object is selected from 1000Da<Average molecular weight<2000Da's is known more Peptide or/and protein standard substance or combinations thereof.In a specific embodiment, the internal standard object is selected from polypeptide P (33507- 63-0), molecular weight 1347.63Da, sequence are SEQ ID NO:1:RPKPQQFFGLM-NH2;Or, being selected from polypeptide P14R (synthetic peptide), molecular weight 1533.85Da, sequence are SEQ ID NO:2:PPPPPPPPPPPPPPR.
In one embodiment, the internal standard object is selected from 2000Da<Average molecular weight<3000Da's is known more Peptide or/and protein standard substance or combinations thereof.In a specific embodiment, the internal standard object is selected from polypeptide A CTH Fragment18-39 (human), molecular weight 2465.19Da, sequence are SEQ ID NO:3: RPVKVYPNGAEDESAEAFPLEF。
In one embodiment, the internal standard object is selected from 12000Da<Average molecular weight<180000Da's is known Polypeptide or/and protein standard substance or combinations thereof.In a specific embodiment, the internal standard object is selected from horse flesh red eggs White Apomyoglobin (equine), molecular weight 16952Da, sequence are SEQ ID NO:4: GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGTVVLTALGGILK KKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKALELFRNDIAAKYKELGFQG。
Also in other embodiments, the internal standard object is selected from above-mentioned average molecular weight range and arbitrarily combines. In one specific embodiment, wherein the internal standard object is selected from peptide material P (33507-63-0) and h-Mb The combination of Apomyoglobin (equine).In another embodiment, the internal standard object is selected from P14R The combination of (synthetic peptide) and h-Mb Apomyoglobin (equine);In other specific embodiment parties In case, the internal standard object is selected from ACTH fragment18-39 (human) and h-Mb Apomyoglobin (equine) combination;And in additional specific embodiments, the internal standard object is selected from peptide material P The combination of (33507-63-0) and ACTH fragment18-39 (human).
Second purpose of the invention is to provide a kind of internal standard object in the above method.
In one embodiment, the internal standard object is selected from 1000Da<Average molecular weight<2000Da's is known more Peptide or/and protein standard substance or combinations thereof.In a specific embodiment, the internal standard object is selected from polypeptide P (33507- 63-0), molecular weight 1347.63Da, sequence are SEQ ID NO:1:RPKPQQFFGLM-NH2;Or, being selected from polypeptide P14R (synthetic peptide), molecular weight 1533.85Da, sequence are SEQ ID NO:2:PPPPPPPPPPPPPPR.
In one embodiment, the internal standard object is selected from 2000Da<Average molecular weight<3000Da's is known more Peptide or/and protein standard substance or combinations thereof.In a specific embodiment, the internal standard object is selected from polypeptide A CTH Fragment18-39 (human), molecular weight 2465.19Da, sequence are SEQ ID NO:3: RPVKVYPNGAEDESAEAFPLEF。
In one embodiment, the internal standard object is selected from 12000Da<Average molecular weight<180000Da's is known Polypeptide or/and protein standard substance or combinations thereof.In a specific embodiment, the internal standard object is selected from horse flesh red eggs White Apomyoglobin (equine), molecular weight 16952Da, sequence are SEQ ID NO:4: GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGTVVLTALGGILK KKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKALELFRNDIAAKYKELGFQG。
Also in other embodiments, the internal standard object is selected from above-mentioned average molecular weight range and arbitrarily combines. In one specific embodiment, wherein the internal standard object is selected from peptide material P (33507-63-0) and h-Mb The combination of Apomyoglobin (equine).In another embodiment, the internal standard object is selected from P14R The combination of (synthetic peptide) and h-Mb Apomyoglobin (equine);In other specific embodiment parties In case, the internal standard object is selected from ACTH fragment18-39 (human) and h-Mb Apomyoglobin (equine) combination;And in additional specific embodiments, the internal standard object is selected from peptide material P The combination of (33507-63-0) and ACTH fragment18-39 (human).
Third purpose of the present invention is to provide a kind of reagent combination for flight time mass spectrum microbiological specimens pre-treatment Object, main component include:Component I:Acetonitrile and formic acid;Component II:Acetonitrile, trifluoroacetic acid and alpha-cyano -4- hydroxycinnamic acids; Component III:Internal standard object described in any of the above-described part.
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:Peptide material P (33507-63-0) (average molecular weight 1347.3Da).
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:P14(average molecular weight is R (synthetic peptide) 1533.85Da)。
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:(average molecular weight is ACTH fragment18-39 (human) 2465.19Da)。
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:(average molecular weight is h-Mb Apomyoglobin (equine) 16952Da)。
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:Peptide material P (33507-63-0) (average molecular weight 1347.3Da), H-Mb Apomyoglobin (equine) (average molecular weight 16952Da).
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:P14(average molecular weight is R (synthetic peptide) 1533.85Da), h-Mb Apomyoglobin (equine) (average molecular weight 16952Da).
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:(average molecular weight is ACTH fragment18-39 (human) 2465.19Da), h-Mb Apomyoglobin (equine) (average molecular weight 16952Da).
In one embodiment, wherein component I includes:The formic acid of the acetonitrile of 50.0% (v/v), 35.0% (v/v), it is remaining Amount is water.Component II includes:The acetonitrile of 52.5% (v/v), the trifluoroacetic acid of 2.5% (v/v), 15mg/ml (m/v) alpha-cyano- 4- hydroxycinnamic acids, surplus are water.Component III includes:Peptide material P (33507-63-0) (average molecular weight 1347.3Da), ACTH fragment18-39 (human) (average molecular weight 2465.19Da).
4th purpose of the invention is to provide by being used for mass spectrum prepared by above-mentioned internal standard object or reagent composition Identify the detection product of unknown microorganism.
In one embodiment, which is the kit that flight time mass spectrum detects microorganism, including:
(1) reagent composition of microbiological specimens pre-treatment;
(2) internal standard compositions.
In one embodiment, which further includes:(3) other reagents for mass spectrogram, including negative quality-control product, positive matter Control product.
In another embodiment, which further includes point sample and Mass Spectrometer Method target piece, and for comparing and school The software of positive reference substance and determinand molecular weight.
Fifth object of the present invention is to provide by passing through above-mentioned internal standard object or reagent composition or detection product For the Internal standard correction methods method of flight time mass spectrum system identification microbiological specimens, step includes:
(1) centrifugation equipped with 10 μ l components I is fallen with sterilizing toothpick (or 1 μ l oeses) suitable single bacterium in picking part Guan Zhong carries out clasmatosis, albumen and polypeptide release, cracks 5 minutes;
(2) 1 μ l of above-mentioned solution are taken to be added on the hole position of target plate, drying at room temperature;
(3) it takes 1 μ l of internal standard object to cover on same hole position, spontaneously dries;
(4) micro-pipe for opening component II pipettes 1 μ l components II and is added on same hole position, spontaneously dries;
(5) target plate is put into flight time mass spectrum system and is detected, wherein by comparing to be measured point of internal standard object The difference of son amount and actual molecular weight, is corrected for the molecular weight of tested microorganism characteristic protein.
In one embodiment, the microorganism detection is to determine the genus and species, subspecies or hypotype of microorganism.At one In specific embodiment, the microorganism detection be non-diagnostic purpose detect pathogenic bacteria, contaminated bacteria, drug-fast bacteria etc., or have The pathogenic bacteria of diagnostic purpose.
In one embodiment, the microorganism in any of the above-described scheme is microorganism in environmental pollution, food quarantine In microorganism, the microorganism in import-export commodity, resistant micro-organism etc. in drug research.
In one embodiment, the microorganism in any of the above-described scheme is prokaryotic micro-organisms, eukaryotic microorganisms.At one In specific embodiment, the prokaryotic micro-organisms includes bacterium.The eukaryotic microorganisms are that fungi includes saccharomycete, mould etc..
Principle and definition
The principle of flight time mass spectrum system identification microorganism is:Different microorganisms, the protein contained is variant, After processing, using flight time mass spectrum system detectio, different microorganisms has its different characteristic fingerprint to microbiological specimens Collection of illustrative plates is compared by flight time mass spectrum network analysis software with the feature spectrogram of known microorganisms in database, Not same species of microorganism is distinguished, that is, provides the qualification result of microorganism.Since the characteristic fingerprint spectrogram of microorganism is flight time matter Spectra system identifies the unique basis for estimation of microorganism, thus spectrogram is accurately the correct premise of microbial identification.Each single Standard substance is added in sample to be tested, after being corrected to single sample by analysis software, then microbial identification is carried out, to improve The accuracy rate of single sample detection.
Although it should be pointed out that the present invention can be used for detect microorganism, the present invention be only to testing result into Row correction, so that testing result is consistent with actual result.Due to by flight time mass spectrum system detectio microorganism, needing The characteristic protein collection of illustrative plates of previously prepared tested microorganism, the inspection can not be completed by relying solely on the internal standard object of the present invention It surveys, therefore detection method according to the present invention and the diagnosis or detection that are not belonging to disease.
Technique effect
(1) present invention adds standard substance by research in micro-biological samples, it is found that the addition of internal standard material can Single microbial sample is corrected, and is used in combination with flight time mass spectrum system micro-biological samples reagent treatment, can be carried The accuracy rate of high microorganism identification, while compensating for and only having external standards to do the deficiency corrected currently on the market;
(2) molecular weight ranges of internal standard material that the present invention is added are other than microbial identification range, and Within detection range, the requirement of detection and correction can reach;
(3) present invention in using internal standard material correction single microbial sample detection method, be applicable to include Fungi, bacterium etc. is all kinds of to be used in the microbiological specimens of MALDI-TOF MS detections.
Description of the drawings
Fig. 1-1:Kirschner citric acid bacillus Citrobacter koseri;Fig. 1-2:Escherichia coli Escherichia coli
Fig. 1-3:Enterococcus faecalis Enterococcus faecalis;Fig. 1-4:Friedlander's bacillus Klebsiella pneumoniae
Fig. 1-5:Stenotrophomonas maltophilia Stenotrophomonas maltophilia
Fig. 1-6:Pseudomonas aeruginosa Pseudomonas aeruginosa;Fig. 1-7:Salmonella Salmonella sp.
Fig. 1-8:Klebsiella oxytoca Klebsiella oxytoca;Fig. 1-9:Human fetal cardiomyocytes Staphylococcus hominis
Fig. 1-10:Acinetobacter baumannii Acinetobacter baumannii
Fig. 1-11:Enterobacter cloacae Enterobacter cloacae;Fig. 1-12:Serratia marcescens Serratia marcescens
Fig. 2-1:Polypeptide mass spectrogram is dissolved using trifluoroacetic acid/acetonitrile organic solvents
Fig. 2-2:Utilize ultrapure water dissolution polypeptide mass spectrogram;Fig. 2-3:Utilize ultrapure water dissolution internal standard composition
Fig. 2-4:Internal standard composition is dissolved using trifluoroacetic acid/acetonitrile
Fig. 3-1:Internal standard is added using patter method processing micro-biological samples Escherichia coli (ATCC8739)
Fig. 3-2:It adds internal standard and utilizes a step treatment by extraction micro-biological samples Escherichia coli (ATCC8739)
Fig. 3-3:Internal standard is added using three step centrifugal process processing micro-biological samples Escherichia coli (ATCC8739)
Fig. 3-4:Mixing addition internal standard composition (internal standard compound pulls open figure);Fig. 3-5:Mixing addition internal standard composition figure
Fig. 4-1:There is the peak of deviation using patter method processing micro-biological samples Escherichia coli (ATCC8739) in addition internal standard Figure
Fig. 4-2:There is deviation again using patter method processing micro-biological samples Escherichia coli (ATCC8739) in addition internal standard To the peak figure after instrumental correction
Fig. 5:There is obvious characteristic peak figure at m/z1351
Fig. 6-1:Staphylococcus haemolyticus;Fig. 6-2:Staphylococcus aureus;Fig. 6-3:Human fetal cardiomyocytes
Fig. 6-4:Pseudomonas aeruginosa;Fig. 6-5:Proteus vulgaris;Fig. 6-6:Klebsiella oxytoca
Fig. 6-7:Acinetobacter bauamnnii;Fig. 6-8:Streptococcusagalactiae;Fig. 6-9:Enterococcus faecium
Fig. 7:Staphylococcus epidermis;Fig. 8:Aeromonas hydrophila
Fig. 9:The protein fingerprint spectrum of Escherichia coli is identified using the ultrapure water dissolution of h-Mb standard substance
Specific implementation mode
In order to further appreciate that the technical characteristic of the present invention, detailed explain is carried out to the present invention with reference to specific embodiment It states.Embodiment only has illustrative effect to the present invention, without the effect of any restrictions, those skilled in the art The modification of any unsubstantiality is made on the basis of the present invention, should all be belonged to the scope of protection of the present invention.
Embodiment one:Microorganism is identified using flight time mass spectrum system micro-biological samples pretreatment reagent kit
Strain culturing and pre-treatment:37 DEG C of cultures 24 of Clinical isolation that more plants of Beijing hospital laboratories are preserved are small When, corresponding single bacterium colony is obtained, target plate is applied to using sterilizing toothpick (or 1 μ l oeses) suitable single bacterium colony in picking part Corresponding point is drawn 1 μ l components I and is covered in the point, spontaneously dries, and draws 1 μ l components II and covers on same hole position, from So after drying, upper machine testing and identification and analysis, qualification result such as table 1 and Fig. 1-1 to Fig. 1-12.
The qualification result of 5 plants of bacterium in 1 embodiment one of table
By above-mentioned qualification result it is found that principal character peak is distributed in microbial biomass spectrogram (see Fig. 1-1 to Fig. 1-12) Between 2000-13000Da, therefore, the internal standard object molecular weight added in the present invention is less than 2000Da or/and is more than When 13000Da, the similar mass spectra peak of microorganism characteristic peak will not be resulted from, to theoretically ensure that the feasible of microbial identification Property and accuracy.
It is prepared by the internal standard composition of two flight time mass spectrum system identification microorganism of embodiment
(1) trifluoroacetic acid/acetonitrile is utilized to dissolve standard substance
Using trifluoroacetic acid/acetonitrile organic solvents (0.1% trifluoroacetic acid and 10% acetonitrile) by polypeptide standard items dry powder (i.e. Polypeptide P (33507-63-0), molecular weight 1347Da) it is dissolved into the solution of 100fmol/ul concentration, 1 μ l are drawn after careful mixing to be covered It covers in target plate point, spontaneously dries, it is rear to draw component in the commercially available flight time mass spectrum system micro-biological samples reagent treatments of 1 μ l II (or other for the matrix liquid in microbial identification) covers same point, after natural drying, time of-flight mass spectrometer It is detected, after instrumental correction, testing result such as Fig. 2-1 of the standard substance has apparent spy at m/z1348.76 Peak is levied, illustrates that the standard substance can use trifluoroacetic acid/acetonitrile dissolving, and there is good detection result.
(2) ultrapure water dissolution standard substance is utilized
Polypeptide standard items dry powder (i.e. polypeptide P (33507-63-0), molecular weight 1347Da) is dissolved into using ultra-pure water The solution of 500fmol/ul concentration is drawn 1 μ l after careful mixing and is covered in target plate point, and after natural drying, it is commercially available to draw 1 μ l Compositionⅱ in flight time mass spectrum system micro-biological samples reagent treatment (or other for the matrix liquid in microbial identification) covers It covers in same point, after natural drying, time of-flight mass spectrometer is detected, testing result such as Fig. 2-2, in m/ There is apparent characteristic peak at z1348.88, illustrates that the standard substance can use ultrapure water dissolution, and there is good detection result.
(3) ultrapure water dissolution internal standard composition is utilized
Peptide material (i.e. polypeptide P (33507-63-0), the molecular weight of final concentration of 500fmol/ μ L are prepared with ultra-pure water 1347Da) and the mixed solution of the P14R (molecular weight 1533) of final concentration of 50fmol/ μ L.1 μ l coverings are drawn after careful mixing Onto target plate point, spontaneously dry, it is rear to draw compositionⅱ in the commercially available flight time mass spectrum system micro-biological samples reagent treatments of 1 μ l (or other for the matrix liquid in microbial identification) covers same point, after natural drying, time of-flight mass spectrometer into Row detection, after instrumental correction, testing result such as Fig. 2-3 of the internal standard composition, in m/z 1348.64 and m/z There is apparent characteristic peak at 1534.65, illustrates that the internal standard composition can use ultrapure water dissolution, and there is good detection result.
(4) trifluoroacetic acid/acetonitrile is utilized to dissolve internal standard composition
It is prepared using trifluoroacetic acid/acetonitrile organic solvents (0.1% trifluoroacetic acid and 10% acetonitrile) final concentration of The mixing of the P14R (molecular weight 1533) of the peptide material (molecular weight 1347Da) of 500fmol/ μ L and final concentration of 50fmol/ μ L Solution.1 μ l are drawn after careful mixing to cover in target plate point, are spontaneously dried, it is rear to draw the commercially available flight time mass spectrum systems of 1 μ l Compositionⅱ in micro-biological samples reagent treatment (or other for the matrix liquid in microbial identification) covers same point, from So after drying, time of-flight mass spectrometer is detected.After instrumental correction, testing result such as Fig. 2-4 of the internal standard composition, There is apparent characteristic peak at m/z1348.48 and m/z1534.48, illustrates that the internal standard composition can have with trifluoroacetic acid/acetonitrile Solvent dissolves, and has good detection result.
Described in figure as above, the theoretical molecular weight (1347.63Da) of internal standard object polypeptide P (33507-63-0) and P14R's There is subtle difference in theoretical molecular weight (1533.85Da), and same internal standard object is (such as with actually detected molecular weight Polypeptide P) each detected value there is also certain difference, this explanation detects the molecular weight mistake of microorganism characteristic protein in laser mass spectrometry Unavoidably there is systematic error in journey.Therefore, in actually detected microbial process, by being added in above-mentioned single or joint Ministerial standard object corrects systematic error, so as to more accurately detect and distinguish different microorganisms and its close molecular weight Characteristic protein.
The internal standard composition adding method of three flight time mass spectrum system identification microorganism of embodiment optimizes
(1) internal standard composition is directly added
Using patter method processing micro-biological samples Escherichia coli (ATCC8739), and internal standard composition is directly appended to sample In this point, concrete operation method is:Sterile toothpick picking Escherichia coli single bacterium colony, is uniformly applied in target plate point, natural After drying, (or the commercially available flight time mass spectrum systems of 1 μ l are covered in sample spot in 1 μ l internal standards composition of same point overlying lid Components I in micro-biological samples reagent treatment covers 1 μ l internal standards composition after natural drying), it spontaneously dries, it is commercially available winged to draw 1 μ l Compositionⅱ (or other are used for the matrix liquid in microbial identification) covering in row time mass spectrum system micro-biological samples reagent treatment Onto same point, time of-flight mass spectrometer detection is carried out after natural drying.After instrumental correction, the testing result of the sample is such as Fig. 3-1 has apparent characteristic peak at m/z1348, and when illustrating using patter method processing microbiological specimens, internal standard composition can It is added directly into sample spot and detects.
Using a step treatment by extraction micro-biological samples Escherichia coli (ATCC8739), and internal standard composition is directly added Onto sample point, concrete operation method is:The commercially available flight time mass spectrum system microorganisms of 30 μ l are added in 200 μ l centrifuge tubes Component I in sample processing reagent is fallen with 1 μ l aseptic inoculations rings or pipette tips picking single bacterium in upper tube, is shaken mixing 5min, is added 1 μ It on l samples to target plate, spontaneously dries, in 1 μ l internal standard compositions of same point overlying lid, spontaneously dries, draw the 1 commercially available flights of μ l Compositionⅱ in time mass spectrum system micro-biological samples reagent treatment (or other for the matrix liquid in microbial identification) covers In same point, time of-flight mass spectrometer detection is carried out after natural drying.After instrumental correction, the testing result of the sample is as schemed 3-2 has apparent characteristic peak at m/z1348, when illustrating using a step treatment by extraction microbiological specimens, internal standard composition It can be added directly into sample spot and detect.
Using three step centrifugal process processing micro-biological samples Escherichia coli (ATCC8739), and internal standard composition is directly added Onto sample point, concrete operation method is:300 μ l pure water are added in 1.5ml or 2ml centrifuge tubes, oese takes large intestine bar Bacterium single bacterium is fallen in upper tube, and concussion is uniform, and 900 μ l ethyl alcohol, concussion are added, and 12000rpm is centrifuged 2 minutes, discarded supernatant, centrifugation 2 Minute, it spontaneously dries, adds 50 μ l70% formic acid, fully shaking that 50 μ l acetonitriles, fully shaking, 12000rpm is added to centrifuge 2 minutes, Add on 1 μ l samples to target plate, spontaneously dry, in 1 μ l internal standard compositions of same point overlying lid, spontaneously dries, it is commercially available to draw 1 μ l Compositionⅱ in flight time mass spectrum system micro-biological samples reagent treatment (or other for the matrix liquid in microbial identification) covers It covers in same point, time of-flight mass spectrometer detection is carried out after natural drying.After instrumental correction, the testing result of the sample Such as Fig. 3-3, there is apparent characteristic peak at m/z1348, when illustrating using three step centrifugal process processing microbiological specimens, internal standard group Conjunction object, which can be added directly into sample spot, to be detected.
(2) mixing addition internal standard composition
1 is pressed using patter method processing micro-biological samples Escherichia coli (ATCC8739), and internal standard composition and matrix liquid: The mixing of 1 ratio is added in sample point, and concrete operation method is:Sterile toothpick picking Escherichia coli single bacterium colony is uniformly smeared It is micro- in 1 μ l internal standards compositions of same point overlying lid and commercially available flight time mass spectrum system after natural drying in target plate point The mixture of compositionⅱ (or other are used for the matrix liquid in microbial identification), spontaneously dries laggard in biological sample reagent treatment Row time of-flight mass spectrometer detects.After instrumental correction, testing result such as Fig. 3-4 and 3-5 of the sample, in m/z1348 and There is apparent characteristic peak at m/z1534, when illustrating using patter method processing microbiological specimens, internal standard composition can be mixed with matrix liquid Conjunction is added in sample spot and detects.
The internal standard composition calibration result of example IV flight time mass spectrum system identification microorganism is evaluated
Using the mass spectrogram of internal standard composition Caliberation Flight time mass spectrum system detectio microorganism, by Escherichia coli (ATCC8739) it is inoculated on Columbia Blood Agar culture medium, 37 DEG C are cultivated 24 hours, and sterile toothpick picking Escherichia coli are single Bacterium colony is uniformly applied in target plate point, after natural drying, in 1 μ l internal standards composition of same point overlying lid (or in sample spot Components I in the commercially available flight time mass spectrum system micro-biological samples reagent treatments of 1 μ l of upper covering, covers 1 μ l internal standards after natural drying Composition), spontaneously dry, draw the commercially available flight time mass spectrum system micro-biological samples reagent treatments of 1 μ l in compositionⅱ (or other For the matrix liquid in microbial identification) same point is covered, time of-flight mass spectrometer detection is carried out after natural drying, it should The testing result of sample such as Fig. 4-1 illustrates that deviation occurs in mass spectra peak in the mass spectrogram without obvious characteristic peak at m/z1348, The Mass Spectrometer Method result of the sample is insincere, need to re-start instrumental correction and gathered data.
Above-mentioned E. coli SampLes judge that deviation occurs in mass spectrogram, again right through internal standard composition characteristic peak m/z1348 values After instrumental correction, mass spectrometric data is acquired, testing result such as Fig. 4-2 has obvious characteristic peak, explanation in the mass spectrogram at m/z 1348 The mass spectra peak of the mass spectrogram does not occur deviation, the Mass Spectrometer Method credible result of the sample.
The internal standard composition calibration result of five flight time mass spectrum system identification microorganism of embodiment is evaluated
Using the mass spectrogram of internal standard composition Caliberation Flight time mass spectrum system detectio microorganism, by Escherichia coli (ATCC8739) it is inoculated on Columbia Blood Agar culture medium, 37 DEG C are cultivated 24 hours, and sterile toothpick picking Escherichia coli are single Bacterium colony is uniformly applied in target plate point, after natural drying, in 1 μ l internal standards composition of same point overlying lid (or in sample spot Components I in the commercially available flight time mass spectrum system micro-biological samples reagent treatments of 1 μ l of upper covering, covers 1 μ l internal standards after natural drying Composition), spontaneously dry, draw the commercially available flight time mass spectrum system micro-biological samples reagent treatments of 1 μ l in compositionⅱ (or other For the matrix liquid in microbial identification) same point is covered, time of-flight mass spectrometer detection is carried out after natural drying, it should The testing result of sample such as Fig. 5, there is apparent characteristic peak at m/z1351, and does not have obvious characteristic peak at m/z1348, Illustrate that deviation occurs in mass spectra peak in the mass spectrogram, which is identified using the identification software containing calibration function, identifies As a result it is Escherichia coli, and its corresponding confidence level score value is 94, illustrates that the internal standard has good calibration result.
Embodiment six utilizes flight time mass spectrum system micro-biological samples reagent treatment and the internal standard composition in the present invention Detect micro-biological samples
Clinical common pathogenic bacteria (table 2) is detected according to the detection of five the method for embodiment, testing result such as Fig. 6-1 To 6-9, qualification result is table 3 after software analyzing processing.
2 clinical common pathogenic bacteria list of table
Bacterium numbering Strain latin name Strain Chinese name
6‐1 Staphylococcus haemolyticus Staphylococcus haemolyticus
6‐2 Staphylococcus aureus Staphylococcus aureus
6‐3 Staphylococcus hominis Human fetal cardiomyocytes
6‐4 Pseudomonas aeruginosa Pseudomonas aeruginosa
6‐5 Proteus vulgaris Proteus vulgaris
6‐6 Klebsiella oxytoca Klebsiella oxytoca
6‐7 Acinetobacter baumannii Acinetobacter bauamnnii
6‐8 Streptococcus agalactiae Streptococcusagalactiae
6‐9 Enterococcus faecium Enterococcus faecium
3 clinical common pathogenic bacteria qualification result of table
Embodiment seven utilizes flight time mass spectrum system micro-biological samples reagent treatment and the internal standard composition in the present invention Detect the pathogenic bacteria of skin infection patient
Suppuration sexual secretion sample at the surgical site infection patient wound of certain hospital is subjected to inoculated and cultured, is obtained doubtful After the single bacterium colony of pathogenic bacteria, carries out micro-biological samples processing using five the method for embodiment and examined using time of-flight mass spectrometer It surveys, obtained testing result such as Fig. 7, qualification result is the staphylococcus epidermis result and full-automatic biochemical assessing instrument qualification result Unanimously.
Embodiment eight utilizes flight time mass spectrum system micro-biological samples reagent treatment and the internal standard composition in the present invention Detect the pathogenic bacteria in food
The results are shown in Figure 8 for Mass Spectrometric Identification.
Embodiment nine identifies Escherichia coli using h-Mb standard substance
Method:Ultrapure water dissolution, the results are shown in Figure 9 for Mass Spectrometric Identification.
Sequence table
<110>Beijing Yixin Bochuang Biotechnology Co., Ltd.
<120>The method and products thereof of detection microorganism is composed by internal standard material
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 11
<212> PRT
<213>Microorganism (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 1
Arg Pro Lys Pro Gln Gln Phe Phe Gly Leu Met
1 5 10
<210> 2
<211> 15
<212> PRT
<213>Microorganism (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 2
Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Pro Arg
1 5 10 15
<210> 3
<211> 22
<212> PRT
<213>Microorganism (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 3
Arg Pro Val Lys Val Tyr Pro Asn Gly Ala Glu Asp Glu Ser Ala Glu
1 5 10 15
Ala Phe Pro Leu Glu Phe
20
<210> 4
<211> 153
<212> PRT
<213>Microorganism (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 4
Gly Leu Ser Asp Gly Glu Trp Gln Gln Val Leu Asn Val Trp Gly Lys
1 5 10 15
Val Glu Ala Asp Ile Ala Gly His Gly Gln Glu Val Leu Ile Arg Leu
20 25 30
Phe Thr Gly His Pro Glu Thr Leu Glu Lys Phe Asp Lys Phe Lys His
35 40 45
Leu Lys Thr Glu Ala Glu Met Lys Ala Ser Glu Asp Leu Lys Lys His
50 55 60
Gly Thr Val Val Leu Thr Ala Leu Gly Gly Ile Leu Lys Lys Lys Gly
65 70 75 80
His His Glu Ala Glu Leu Lys Pro Leu Ala Gln Ser His Ala Thr Lys
85 90 95
His Lys Ile Pro Ile Lys Tyr Leu Glu Phe Ile Ser Asp Ala Ile Ile
100 105 110
His Val Leu His Ser Lys His Pro Gly Asp Phe Gly Ala Asp Ala Gln
115 120 125
Gly Ala Met Thr Lys Ala Leu Glu Leu Phe Arg Asn Asp Ile Ala Ala
130 135 140
Lys Tyr Lys Glu Leu Gly Phe Gln Gly
145 150

Claims (3)

1. a kind of kit of flight time mass spectrum detection microorganism, including:
(1) reagent composition of microbiological specimens pre-treatment;
(2)1000Da<Average molecular weight<3000Da and 12000Da<Average molecular weight<The internal standard object of 20000Da combines Object;
The wherein described internal standard object is selected from 1000Da<Average molecular weight<The polypeptide P (33507-63-0) of 2000Da and/or more Peptide P14R(synthetic peptide);And/or
The wherein described internal standard object is selected from 2000Da<Average molecular weight<The polypeptide A CTH fragment18-39 of 3000Da (human);
And wherein the internal standard object is selected from 12000Da<Average molecular weight<The h-Mb of 180000Da Apomyoglobin(equine)。
2. kit as described in claim 1, the wherein kit further include:
(3) other reagents for mass spectrogram, including negative quality-control product, positive quality control product.
3. kit as claimed in claim 1 or 2, the wherein kit further include point sample and Mass Spectrometer Method target piece, and For comparing the software with calibration standard object and determinand molecular weight.
CN201810345986.4A 2016-11-25 2016-11-25 Kit for detecting microorganisms by internal standard substance spectrum Active CN108519267B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810345986.4A CN108519267B (en) 2016-11-25 2016-11-25 Kit for detecting microorganisms by internal standard substance spectrum

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810345986.4A CN108519267B (en) 2016-11-25 2016-11-25 Kit for detecting microorganisms by internal standard substance spectrum
CN201611062751.1A CN107024530B (en) 2016-11-25 2016-11-25 Method that detection microorganism is composed by internal standard material and products thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201611062751.1A Division CN107024530B (en) 2016-11-25 2016-11-25 Method that detection microorganism is composed by internal standard material and products thereof

Publications (2)

Publication Number Publication Date
CN108519267A true CN108519267A (en) 2018-09-11
CN108519267B CN108519267B (en) 2020-06-05

Family

ID=59525944

Family Applications (4)

Application Number Title Priority Date Filing Date
CN201810345905.0A Active CN108802162B (en) 2016-11-25 2016-11-25 Method for detecting microorganisms by internal standard substance spectrum
CN201810345986.4A Active CN108519267B (en) 2016-11-25 2016-11-25 Kit for detecting microorganisms by internal standard substance spectrum
CN201611062751.1A Expired - Fee Related CN107024530B (en) 2016-11-25 2016-11-25 Method that detection microorganism is composed by internal standard material and products thereof
CN201810346086.1A Active CN108593753B (en) 2016-11-25 2016-11-25 Internal standard correction method for detecting microorganisms through internal standard substance spectrum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201810345905.0A Active CN108802162B (en) 2016-11-25 2016-11-25 Method for detecting microorganisms by internal standard substance spectrum

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201611062751.1A Expired - Fee Related CN107024530B (en) 2016-11-25 2016-11-25 Method that detection microorganism is composed by internal standard material and products thereof
CN201810346086.1A Active CN108593753B (en) 2016-11-25 2016-11-25 Internal standard correction method for detecting microorganisms through internal standard substance spectrum

Country Status (1)

Country Link
CN (4) CN108802162B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018078167A1 (en) * 2016-10-31 2018-05-03 Universität Zürich Protein screening and detection method
CN108085421B (en) * 2018-01-24 2018-12-04 北京毅新博创生物科技有限公司 The method and products thereof of mass spectrography detection influenza A virus multiple PCR products
CN109900774B (en) * 2018-12-13 2020-07-28 中国科学院生态环境研究中心 Method for improving detection sensitivity of MA L DI-TOF-MS to PS micro/nano particles
CN109884160A (en) * 2019-02-26 2019-06-14 中国矿业大学 Using the method for mode identification technology identification Carbapenem-resistant paracolon
TWI700492B (en) * 2019-09-17 2020-08-01 長庚大學 Molding characteristic mass spectrum and identification model establishment method and method of analysis and identification of microbial characterization
CN111876343A (en) * 2020-06-24 2020-11-03 四川省农业科学院分析测试中心 Mass spectrometry method for detecting Klebsiella pneumoniae in instant fresh fruits and vegetables
CN112540139B (en) * 2020-12-16 2022-07-15 杭州汇健科技有限公司 Molecular weight calibrator kit for metabolic profiling detection, and preparation method and use method thereof
CN113933377A (en) * 2021-09-28 2022-01-14 深圳湾实验室 Compound and mass spectrum standard substance and calibration substance thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101155924A (en) * 2005-04-05 2008-04-02 爱尔伯股份公司 Production of highly isotopically labelled, secondary, microbial metabolic products, and corresponding metabolic products
US20090011447A1 (en) * 2006-05-25 2009-01-08 Banoub Joseph H Quantification of vitellogenin
CN101363056A (en) * 2008-09-11 2009-02-11 浙江大学 High-flux microorganism identification method
CN102998361A (en) * 2012-11-19 2013-03-27 中国计量科学研究院 Method for valuing standard substance of C reaction protein
CN103052872A (en) * 2010-10-29 2013-04-17 Atonarp株式会社 Sampling apparatus
WO2015117133A1 (en) * 2014-02-03 2015-08-06 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
CN105143872A (en) * 2013-06-07 2015-12-09 皮尔斯生物科技有限公司 Absolute quantitation of proteins and protein modifications by mass spectrometry with multiplexed internal standards
JP2016128812A (en) * 2010-03-12 2016-07-14 イョットペーテー・ペプタイド・テクノロジーズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングJpt Peptide Technologies Gmbh Method for determining concentration of peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101963595A (en) * 2010-09-02 2011-02-02 毅新兴业(北京)科技有限公司 Serum polypeptide internal standard correction detection method
CN102337341B (en) * 2011-10-21 2014-01-08 马庆伟 MALDI-TOF (Matrix-assisted laser desorption/ionization-Time-of-flight) mass spectrum double internal standard and quantitative detecting method thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101155924A (en) * 2005-04-05 2008-04-02 爱尔伯股份公司 Production of highly isotopically labelled, secondary, microbial metabolic products, and corresponding metabolic products
US20090011447A1 (en) * 2006-05-25 2009-01-08 Banoub Joseph H Quantification of vitellogenin
CN101363056A (en) * 2008-09-11 2009-02-11 浙江大学 High-flux microorganism identification method
JP2016128812A (en) * 2010-03-12 2016-07-14 イョットペーテー・ペプタイド・テクノロジーズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングJpt Peptide Technologies Gmbh Method for determining concentration of peptide
CN103052872A (en) * 2010-10-29 2013-04-17 Atonarp株式会社 Sampling apparatus
CN103299184A (en) * 2010-10-29 2013-09-11 Atonarp株式会社 Analysis apparatus
CN102998361A (en) * 2012-11-19 2013-03-27 中国计量科学研究院 Method for valuing standard substance of C reaction protein
CN105143872A (en) * 2013-06-07 2015-12-09 皮尔斯生物科技有限公司 Absolute quantitation of proteins and protein modifications by mass spectrometry with multiplexed internal standards
WO2015117133A1 (en) * 2014-02-03 2015-08-06 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
战晓微等: "沙门氏菌MALDI-TOF-MS检测方法的建立", 《现代食品科技》 *

Also Published As

Publication number Publication date
CN108802162B (en) 2020-08-18
CN108519267B (en) 2020-06-05
CN107024530A (en) 2017-08-08
CN108593753B (en) 2020-06-05
CN107024530B (en) 2018-06-05
CN108593753A (en) 2018-09-28
CN108802162A (en) 2018-11-13

Similar Documents

Publication Publication Date Title
CN107024530B (en) Method that detection microorganism is composed by internal standard material and products thereof
CN103308696B (en) Brucella rapid detection kit based on mass-spectrometric technique
CN107024370B (en) A kind of kit of flight time mass spectrum system micro-biological samples pre-treatment
Steensels et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of bacteria and yeasts in a clinical microbiological laboratory: a review
AU2008204257A1 (en) Means for identifying a strain isolated from a clinical sample at the species and/or subspecies level
CN112946053B (en) Characteristic polypeptide composition for preparing detection product for diagnosing new coronavirus infection
CN107629960A (en) From the reagent and method and method for determining bacteria of positive blood separation of bacterial
Durand et al. Assessment of VITEK® MS IVD database V3. 0 for identification of Nocardia spp. using two culture media and comparing direct smear and protein extraction procedures
Song et al. Using MALDI-TOF-MS to test Staphylococcus aureus–infected vitreous
CN107085034A (en) MALDI TOF MS identify shigella sonnei
TWI775205B (en) Method of identification of methicillin-resistant staphylococcus aureus
CN102749233A (en) Pretreatment method for directly detecting infection urine pathogen by MALDI-TOF MS
CN107860819B (en) Pathogen sample pretreatment method suitable for MALDI-TOF MS detection and application thereof
CN104833803B (en) The multiple detection method of a kind of bean pathogenetic bacteria and data base
CN107917950B (en) Pretreatment method of pathogenic bacteria sample with biosafety
CN112051321A (en) Rapid antibiotic sensitivity testing method combining deuterium water culture and matrix-assisted laser desorption ionization time-of-flight mass spectrometry
US11352655B2 (en) Method of identification of methicillin-resistant Staphylococcus aureus
Li et al. Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry as Internship Teaching Content in Laboratory Medicine.
RU2807137C1 (en) Technique for determining film-forming function of pseudomonads based on mass spectrometry using maldi-tof method
Liang et al. Reliability of muramic acid as a bacterial biomarker is influenced by methodological artifacts from streptomycin
CN116296648A (en) Pretreatment reagent composition for mass spectrum detection of respiratory tract pathogen infection and detection kit thereof
CN106442963B (en) A kind of method and its kit detecting the substance for causing anaphylactoid reaction
CN116298303A (en) Use of pretreatment reagent composition for preparing mass spectrum detection kit for detecting respiratory tract pathogens
Kumar et al. MALDI-TOF MS: A Rapid Way to Identify Bacteria
Alsharabasi APPLICATION OF MALDI-TOF MASS SPECTROMETRY AS A TOOL FOR BIOTYPING OF B. MELITENSIS

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant